ArticleMolecular cancer therapeutics2021

Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.

Nyree Crawford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.